CD133(+) brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence

por Garg, N, Bakhshinyan, D, Venugopal, C, Mahendram, S, Rosa, D A, Vijayakumar, T, Manoranjan, B, Hallett, R, McFarlane, N, Delaney, K H, Kwiecien, J M, Arpin, C C, Lai, P-S, Gómez-Biagi, R F, Ali, A M, de Araujo, E D, Ajani, O A, Hassell, J A, Gunning, P T, Singh, S K
Publicado 2017

INTERCEPTING BRAIN METASTASES THROUGH METABOLIC VULNERABILITIES

por Kieliszek, A M, Mobilio, D, Bassey-Archibong, B I, Johnson, J W, Piotrowski, M L, Aghaei, N, Gwynne, W D, Escudero, L, Chafe, S, Zhang, K Zhai1 C, Quaile, A, McKenna, D, Subapanditha, M, de Araujo, E D, Sedighi, A, Gunning, P T, Tokar, T, Venugopal, C, Montenegro-Burke, J R, Magolan, J, Singh, S K
Publicado 2023